Physician profile
Robert H Zwick
NPI 1699739730
$490.80
in general payments reported to CMS, 2019-2025
9 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55.72 · 2020: $8.71 · 2021: $19.49 · 2022: $148 · 2023: $139 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $259.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $258.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $239.77 | 2022-2025 | Grafix Pl, Stravix, Grafix Xc |
| Mimedx Group, INC. | $64.40 | 2025 | |
| Bard Peripheral Vascular, INC. | $58.63 | 2022 | |
| Kci USA, INC. | $41.50 | 2019-2023 | Promogran Prisma, 3m Cavilon, V.A.C. Dermatac |
| Astrazeneca Pharmaceuticals LP | $22.99 | 2019 | |
| Solventum Corporation | $21.39 | 2025 | 3m Coban, Kerramax Care, 3m Cavilon |
| Organogenesis INC. | $19.49 | 2021 | |
| Opko Pharmaceuticals, LLC | $13.92 | 2019 | |
| Medela LLC | $8.71 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Zwick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.